Literature DB >> 20565046

The prevalence of hopelessness among adults: disability and other related factors.

Onur Hamzaoglu1, Ozlem Ozkan, Mahir Ulusoy, Feray Gokdogan.   

Abstract

BACKGROUND: Hopelessness has become an important issue in the fields of health and social care.
OBJECTIVE: This study aims to determine the prevalence of hopelessness and its association with the current health condition, disability, and other socio-demographic characteristics.
METHOD: The cross-sectional study sampled a population of 501 adults in Bolu, Turkey. Questionnaires included the Household Questionnaire, the Health Condition Questionnaire, Beck Hopelessness Scale, and Brief Disability Questionnaire. Data were collected through face-to-face home interviews between September 29 and October 11, 2003.
RESULTS: The prevalence of hopelessness was 30.9%. It was higher among the literate (60.0%) (p < 0.05), males (35.0%) (p > 0.05), and agricultural workers and peasants (50.0%, 41.9%) (p < 0.05). Almost half of the participants were disabled, and 44.6% of the subjects with disabilities were hopeless (p < 0.05). Being without hope was statistically significant with gender, social class, perceived health, and disability (p < 0.05). The risk of hopelessness increased in subjects with perceived bad health, lowered social class, and disability, compared with the reference groups.
CONCLUSIONS: In this study, hopelessness prevalence was high and it was also associated with the current state of health, perceived health, disability, and some socio-demographic variables. It will be important to increase the number of studies related to hopelessness and associated factors for improved mental health services planning at population level.

Entities:  

Mesh:

Year:  2010        PMID: 20565046     DOI: 10.2190/PM.40.1.f

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  1 in total

1.  Disease risk analysis for schizophrenia patients by an automatic AHP framework.

Authors:  Wenyan Tan; Heng Weng; Haicheng Lin; Aihua Ou; Zehui He; Fujun Jia
Journal:  BMC Med Inform Decis Mak       Date:  2022-01-11       Impact factor: 2.796

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.